Research ExplorerPublicationsConcomitant gain of 1q21 and MYC translocation define a poor...

Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma

Standard

Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma. / Weinhold, Niels; Kirn, Desiree; Seckinger, Anja; Hielscher, Thomas; Granzow, Martin; Bertsch, Uta; Egerer, Gerlinde; Salwender, Hans; Blau, Igor W; Weisel, Katja; Hillengass, Jens; Raab, Marc S; Hose, Dirk; Goldschmidt, Hartmut; Jauch, Anna.

In: HAEMATOLOGICA, Vol. 101, No. 3, 03.2016, p. e116-9.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Weinhold, N, Kirn, D, Seckinger, A, Hielscher, T, Granzow, M, Bertsch, U, Egerer, G, Salwender, H, Blau, IW, Weisel, K, Hillengass, J, Raab, MS, Hose, D, Goldschmidt, H & Jauch, A 2016, 'Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma', HAEMATOLOGICA, vol. 101, no. 3, pp. e116-9. https://doi.org/10.3324/haematol.2015.136929

APA

Weinhold, N., Kirn, D., Seckinger, A., Hielscher, T., Granzow, M., Bertsch, U., Egerer, G., Salwender, H., Blau, I. W., Weisel, K., Hillengass, J., Raab, M. S., Hose, D., Goldschmidt, H., & Jauch, A. (2016). Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma. HAEMATOLOGICA, 101(3), e116-9. https://doi.org/10.3324/haematol.2015.136929

Vancouver

Weinhold N, Kirn D, Seckinger A, Hielscher T, Granzow M, Bertsch U et al. Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma. HAEMATOLOGICA. 2016 Mar;101(3):e116-9. https://doi.org/10.3324/haematol.2015.136929

Bibtex

@article{99f59f96631f4268b70729546ca8e560,
title = "Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma",
keywords = "Antineoplastic Agents, Chromosomes, Human, Pair 1, Gene Deletion, Gene Expression, Genetic Loci, Humans, Multiple Myeloma, Mutagenesis, Insertional, Neoplasm Staging, Plasma Cells, Ploidies, Prognosis, Proto-Oncogene Proteins c-myc, Survival Analysis, Translocation, Genetic, Clinical Trial, Letter, Research Support, Non-U.S. Gov't",
author = "Niels Weinhold and Desiree Kirn and Anja Seckinger and Thomas Hielscher and Martin Granzow and Uta Bertsch and Gerlinde Egerer and Hans Salwender and Blau, {Igor W} and Katja Weisel and Jens Hillengass and Raab, {Marc S} and Dirk Hose and Hartmut Goldschmidt and Anna Jauch",
year = "2016",
month = mar,
doi = "10.3324/haematol.2015.136929",
language = "English",
volume = "101",
pages = "e116--9",
journal = "HAEMATOLOGICA",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "3",

}

RIS

TY - JOUR

T1 - Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma

AU - Weinhold, Niels

AU - Kirn, Desiree

AU - Seckinger, Anja

AU - Hielscher, Thomas

AU - Granzow, Martin

AU - Bertsch, Uta

AU - Egerer, Gerlinde

AU - Salwender, Hans

AU - Blau, Igor W

AU - Weisel, Katja

AU - Hillengass, Jens

AU - Raab, Marc S

AU - Hose, Dirk

AU - Goldschmidt, Hartmut

AU - Jauch, Anna

PY - 2016/3

Y1 - 2016/3

KW - Antineoplastic Agents

KW - Chromosomes, Human, Pair 1

KW - Gene Deletion

KW - Gene Expression

KW - Genetic Loci

KW - Humans

KW - Multiple Myeloma

KW - Mutagenesis, Insertional

KW - Neoplasm Staging

KW - Plasma Cells

KW - Ploidies

KW - Prognosis

KW - Proto-Oncogene Proteins c-myc

KW - Survival Analysis

KW - Translocation, Genetic

KW - Clinical Trial

KW - Letter

KW - Research Support, Non-U.S. Gov't

U2 - 10.3324/haematol.2015.136929

DO - 10.3324/haematol.2015.136929

M3 - SCORING: Journal article

C2 - 26611471

VL - 101

SP - e116-9

JO - HAEMATOLOGICA

JF - HAEMATOLOGICA

SN - 0390-6078

IS - 3

ER -